2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

In Vivo Gene Therapy: Current Approaches and Future Directions

The Cell & Gene Therapy World Conference 2026 will feature an in vivo gene therapy session exploring the latest techniques and breakthroughs. Experts will highlight current strategies using viral and non-viral vectors for direct gene delivery and the challenges in targeting specific tissues. The session will also discuss future advancements in the field, including enhancing safety and efficacy and the potential of in vivo gene therapy to treat genetic disorders and cancers. Attendees will learn how these therapies will evolve and expand in the coming years.

 

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis